How much will sotatercept cost? Unpacking the price of Merck's Winrevair
•
3 min read
Following its FDA approval in March 2024, the manufacturer Merck set the list price for a single vial of sotatercept (brand name Winrevair) at $14,000. This article provides an in-depth look at the cost implications of this groundbreaking pulmonary arterial hypertension (PAH) therapy and answers the critical question: how much will sotatercept cost?
